Kwangdong Healthbio Co., Ltd.
KKRX:0862201,289.00
KRW
+92.00
(+7.69%)
ISIN
KR7086220001
Return %
Stock
S&P 500
1Y
-2.05
14.39
3Y
-55.55
81.42
5Y
-54.05
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Hwa-Young Jung
- Full Time Employees
- 218
- Sector
- Consumer non-durables
- Industry
- Food: major diversified
- Address
- Cheongju-si South Korea
- IPO Date
- Jul 9, 2015
- Similar Companies
- Business
- Kwangdong Healthbio Co., Ltd. is a South Korea-based bio-health and functional nutrition manufacturing company primarily engaged in the research, development, formulation, and original equipment manufacturing (OEM) and original design manufacturing (ODM) of health functional foods, dietary supplements, functional skincare products, and general foods. The company manufactures and supplies an extensive range of healthcare and nutritional formulations across multiple delivery formats, including: coated and uncoated tablets for multi-vitamins, minerals, and bone health; softgel and hard capsules for lipid-based supplements, herbal oils, and immune support; powder blends and stick-pack granules for probiotics, gut wellness, and dietary fibers; liquid pouches, tonics, and concentrated botanical ampoules for fatigue recovery and vitality; chewable tablets, gummies, and jelly sticks for metabolic and beauty-from-within applications; functional cosmetics, including skin lotions, hydrating creams, and facial sheet masks; and proprietary individually recognized functional ingredients and bio-derived natural extracts, such as Andrographis paniculata extract for joint health, rosemary and grapefruit extract complexes for UV-induced skin protection, and Moro blood orange extract for body fat management. The company operates advanced Good Manufacturing Practice (GMP) and Hazard Analysis Critical Control Point (HACCP) certified manufacturing facilities in Ochang, providing end-to-end turnkey services—encompassing raw material screening, clinical efficacy validation, formulation design, pilot production, packaging, and regulatory consulting—to pharmaceutical enterprises, wellness brands, distribution networks, and home-shopping retailers across South Korea and select overseas markets. Founded in December 1992 as Natural F&P Co., Ltd. and formerly known as BL Healthcare Co., Ltd., the company is headquartered in Cheongju-si, Chungcheongbuk-do, South Korea, and trades on the KOSDAQ under the ticker 086220. In December 2023, Kwang Dong Pharmaceutical Co., Ltd. acquired a 58.74% controlling equity stake in the company for KRW 30 billion to internalize health food production capabilities and drive group-level portfolio diversification. Following the acquisition, the company officially changed its corporate name from BL Healthcare Co., Ltd. to Kwangdong Healthbio Co., Ltd. in March 2024, restructured its executive leadership, and completed capital enhancement measures to strengthen operational liquidity, integrate supply chains, and accelerate the commercialization of high-value functional ingredients within the Kwang Dong Pharmaceutical ecosystem.